News Conference News EuroPCR 2025 Short DAPT Safe in ACS With No Ischemic Penalty: 4D-ACS L.A. McKeown May 30, 2025
News Conference News EuroPCR 2021 The Skinny on Ultrathin DES: Meta-analysis Shows Some Long-term Advantages L.A. McKeown May 19, 2021
News Conference News AHA 2020 Latest Post-DES Drug Trial Tests Aspirin Monotherapy After 1 Month of DAPT Shelley Wood November 15, 2020
News Conference News CRT 2020 PCI-Related MIs Not Linked to Mortality at 1 Year: Onyx ONE Michael O'Riordan February 25, 2020
News Conference News TCT 2019 Onyx ONE: Shorter DAPT Plus ZES Noninferior to Polymer-Free Stent in High-Bleeding-Risk Patients L.A. McKeown September 26, 2019
News Conference News TCT 2018 CORRECTION: Polymer-Free BioFreedom Stent Faces Off Against Orsiro Michael O'Riordan September 22, 2018
News Conference News TCT 2018 The End of BMS? LEADERS FREE II Shows Superiority of Polymer-Free, Drug-Coated Stent Yael L. Maxwell September 22, 2018
News Conference News TCT 2017 DES With Bioresorbable Polymer Outperforms BMS in SENIOR Patients Michael O'Riordan November 01, 2017
News Conference News TCT 2016 LEADERS FREE: Polymer-Free DES Maintains Superior Safety, Efficacy Over BMS at 2 Years Yael L. Maxwell October 30, 2016
News Conference News EuroPCR 2016 Last Window for BMS Closes as LEADERS-FREE Supports DES in High-Bleeding-Risk ACS Michael O'Riordan May 17, 2016
News Conference News TCT 2015 LEADERS FREE: Drug-Coated Stent Bests BMS in High-Risk PCI Patients Yael L. Maxwell October 14, 2015
News Conference News TCT 2012 Positive Long-Term Results from LEADERS, BioFreedom FIM, ISAR-TEST 5 October 24, 2012